Retaining Short-term Training Effects on Gait Adaptability in People With Stroke (ATTAINS)
Stroke

About this trial
This is an interventional treatment trial for Stroke
Eligibility Criteria
Inclusion Criteria: > 6 months after first unilateral supratentorial stroke (chronic phase) Able to walk at least 10 minutes independently Initial involvement of the lower extremity after stroke. Having completed (minimal 8/10 training sessions) the 5 week gait adaptability training program using the C-Mill Exclusion Criteria: Any other neurological or musculoskeletal disease affecting gait or balance (e.g. Parkinson's disease, knee osteoarthritis) Contractures or spasticity requiring other treatment (e.g. botulinum toxin treatment) within the duration of the training period. Severe cognitive or visuo-spatial impairments limiting comprehension of instructions or correct perception of the environments
Sites / Locations
- Sint Maartenskliniek
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
No Intervention
Booster group
Home-based exercise group
Control group
Participants assigned to the booster group will receive a three single training sessions 3 months apart targeting gait adaptability using the C-mill. Assessments will take place after giving informed consent which is indicated as the start of the study (baseline), 6 months and 12 months post-baseline.
Participants assigned to the home-based exercise group will receive a program for training at home aiming at a minimum training time of 60 minutes per week. Assessments will take place after giving informed consent which is indicated as the start of the study (baseline), 6 months and 12 months post-baseline
Participants assigned to the control group will not follow any additional intervention other than the standard care they already receive for the year following the completion of the 5-week gait adaptability training using the C-Mill from the ATTAINS study. Assessments will take place after giving informed consent which is indicated as the start of the study(baseline), 6 months and 12 months post-baseline.